Cargando…
Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516223/ https://www.ncbi.nlm.nih.gov/pubmed/37565288 http://dx.doi.org/10.1089/thy.2022.0707 |
| _version_ | 1785109094563053568 |
|---|---|
| author | Wadsley, Jon Ainsworth, Gemma Coulson, Amy Beth Garcez, Kate Moss, Laura Newbold, Kate Farnell, Kate Swain, Jayne Howard, Helen Beasley, Matthew Weaver, Andrew Wood, Katie Marshall, Jennifer Griffin, Matthew Pascoe, Abigail Du, Yong Taprogge, Jan Flux, Glenn Brown, Sarah |
| author_facet | Wadsley, Jon Ainsworth, Gemma Coulson, Amy Beth Garcez, Kate Moss, Laura Newbold, Kate Farnell, Kate Swain, Jayne Howard, Helen Beasley, Matthew Weaver, Andrew Wood, Katie Marshall, Jennifer Griffin, Matthew Pascoe, Abigail Du, Yong Taprogge, Jan Flux, Glenn Brown, Sarah |
| author_sort | Wadsley, Jon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10516223 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Mary Ann Liebert, Inc., publishers |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105162232023-10-19 Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy Wadsley, Jon Ainsworth, Gemma Coulson, Amy Beth Garcez, Kate Moss, Laura Newbold, Kate Farnell, Kate Swain, Jayne Howard, Helen Beasley, Matthew Weaver, Andrew Wood, Katie Marshall, Jennifer Griffin, Matthew Pascoe, Abigail Du, Yong Taprogge, Jan Flux, Glenn Brown, Sarah Thyroid Research Letters Mary Ann Liebert, Inc., publishers 2023-09-01 2023-09-13 /pmc/articles/PMC10516223/ /pubmed/37565288 http://dx.doi.org/10.1089/thy.2022.0707 Text en © Jon Wadsley et al., 2023; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Research Letters Wadsley, Jon Ainsworth, Gemma Coulson, Amy Beth Garcez, Kate Moss, Laura Newbold, Kate Farnell, Kate Swain, Jayne Howard, Helen Beasley, Matthew Weaver, Andrew Wood, Katie Marshall, Jennifer Griffin, Matthew Pascoe, Abigail Du, Yong Taprogge, Jan Flux, Glenn Brown, Sarah Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy |
| title | Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy |
| title_full | Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy |
| title_fullStr | Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy |
| title_full_unstemmed | Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy |
| title_short | Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy |
| title_sort | results of the sel-i-metry phase ii trial on resensitization of advanced iodine refractory differentiated thyroid cancer to radioiodine therapy |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516223/ https://www.ncbi.nlm.nih.gov/pubmed/37565288 http://dx.doi.org/10.1089/thy.2022.0707 |
| work_keys_str_mv | AT wadsleyjon resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT ainsworthgemma resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT coulsonamybeth resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT garcezkate resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT mosslaura resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT newboldkate resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT farnellkate resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT swainjayne resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT howardhelen resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT beasleymatthew resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT weaverandrew resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT woodkatie resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT marshalljennifer resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT griffinmatthew resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT pascoeabigail resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT duyong resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT taproggejan resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT fluxglenn resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy AT brownsarah resultsoftheselimetryphaseiitrialonresensitizationofadvancediodinerefractorydifferentiatedthyroidcancertoradioiodinetherapy |